Moderna (Germany) Performance

0QF Stock  EUR 44.24  1.45  3.39%   
Moderna holds a performance score of 18 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.2, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Moderna are expected to decrease by larger amounts. On the other hand, during market turmoil, Moderna is expected to outperform it. Use Moderna downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to analyze future returns on Moderna.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Moderna are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Moderna reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1
Down 80, Should You Buy the Dip on Moderna - The Motley Fool
12/19/2025
2
Moderna V940Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story - Seeking Alpha
01/13/2026
3
Moderna Joins Elite Club Of Stocks With RS Ratings Over 90 - Investors Business Daily
01/20/2026
4
Why Modernas Stock Is Dropping Despite Cancer Hopes - TipRanks
01/23/2026
5
Moderna Shifts Vaccine Funding Approach And Expands mRNA Oncology Ambitions - simplywall.st
01/29/2026
6
Moderna Stock Falls Amid Market Uptick What Investors Need to Know - Nasdaq
02/02/2026
7
Defiance adds single stock ETFs tied to Zeta Global, Moderna - Structured Retail Products
02/05/2026
8
Moderna shares slide 7 percent after FDA refuses to review flu vaccine - Investing.com
02/10/2026
9
Earnings live Moderna stock pops on revenue growth, Rivian surges, Applied Materials jumps - Yahoo Finance
02/13/2026
10
RBC raises Moderna stock price target to 30 on pipeline progress - Investing.com
02/17/2026
11
Piper Sandler raises Moderna stock price target on vaccine pipeline - Investing.com
02/23/2026
Begin Period Cash Flow2.9 B
Free Cash Flow-4.1 B
  

Moderna Relative Risk vs. Return Landscape

If you would invest  2,181  in Moderna on November 28, 2025 and sell it today you would earn a total of  2,243  from holding Moderna or generate 102.84% return on investment over 90 days. Moderna is currently producing 1.3369% returns and takes up 5.6258% volatility of returns over 90 trading days. Put another way, 50% of traded stocks are less volatile than Moderna, and 74% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Moderna is expected to generate 7.45 times more return on investment than the market. However, the company is 7.45 times more volatile than its market benchmark. It trades about 0.24 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Moderna Target Price Odds to finish over Current Price

The tendency of Moderna Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 44.24 90 days 44.24 
under 4
Based on a normal probability distribution, the odds of Moderna to move above the current price in 90 days from now is under 4 (This Moderna probability density function shows the probability of Moderna Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Moderna has a beta of -1.2. This suggests as returns on its benchmark rise, returns on holding Moderna are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Moderna is expected to outperform its benchmark. Moreover Moderna has an alpha of 1.3615, implying that it can generate a 1.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Moderna Price Density   
       Price  

Predictive Modules for Moderna

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Moderna. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
39.5245.1950.86
Details
Intrinsic
Valuation
LowRealHigh
26.7132.3848.66
Details
Naive
Forecast
LowNextHigh
45.8451.5157.18
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-117.340.8648.77
Details

Moderna Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Moderna is not an exception. The market had few large corrections towards the Moderna's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Moderna, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Moderna within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.36
β
Beta against Dow Jones-1.2
σ
Overall volatility
7.29
Ir
Information ratio 0.21

Moderna Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Moderna for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Moderna can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Moderna is way too risky over 90 days horizon
Moderna appears to be risky and price may revert if volatility continues
The company reported the revenue of 3.2 B. Net Loss for the year was (3.56 B) with loss before overhead, payroll, taxes, and interest of (2.06 B).
Moderna has accumulated about 7.99 B in cash with (3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.8.
Over 77.0% of the company shares are owned by institutions such as pension funds
Latest headline from news.google.com: Piper Sandler raises Moderna stock price target on vaccine pipeline - Investing.com

Moderna Fundamentals Growth

Moderna Stock prices reflect investors' perceptions of the future prospects and financial health of Moderna, and Moderna fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Moderna Stock performance.

About Moderna Performance

By analyzing Moderna's fundamental ratios, stakeholders can gain valuable insights into Moderna's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Moderna has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Moderna has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 64.34  61.12 
Return On Tangible Assets(0.23)(0.22)
Return On Capital Employed(0.30)(0.28)
Return On Assets(0.23)(0.22)
Return On Equity(0.33)(0.31)

Things to note about Moderna performance evaluation

Checking the ongoing alerts about Moderna for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Moderna help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Moderna is way too risky over 90 days horizon
Moderna appears to be risky and price may revert if volatility continues
The company reported the revenue of 3.2 B. Net Loss for the year was (3.56 B) with loss before overhead, payroll, taxes, and interest of (2.06 B).
Moderna has accumulated about 7.99 B in cash with (3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.8.
Over 77.0% of the company shares are owned by institutions such as pension funds
Latest headline from news.google.com: Piper Sandler raises Moderna stock price target on vaccine pipeline - Investing.com
Evaluating Moderna's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Moderna's stock performance include:
  • Analyzing Moderna's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Moderna's stock is overvalued or undervalued compared to its peers.
  • Examining Moderna's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Moderna's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Moderna's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Moderna's stock. These opinions can provide insight into Moderna's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Moderna's stock performance is not an exact science, and many factors can impact Moderna's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk